PortalPublikationenAXIS: a trial of intravenous granulocyte colony-stimulating ...

AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke.

Standard

AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. / Schäbitz, Wolf R; Laage, Rico; Vogt, Gerhard; Koch, Winfried; Kollmar, Rainer; Schwab, Stefan; Schneider, Dietmar; Hamann, Gerhard F; Rosenkranz, Michael; Veltkamp, Roland; Fiebach, Jochen B; Hacke, Werner; Grotta, James C; Fisher, Marc; Schneider, Armin.

in: STROKE, Jahrgang 41, Nr. 11, 11, 2010, S. 2545-2551.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Schäbitz, WR, Laage, R, Vogt, G, Koch, W, Kollmar, R, Schwab, S, Schneider, D, Hamann, GF, Rosenkranz, M, Veltkamp, R, Fiebach, JB, Hacke, W, Grotta, JC, Fisher, M & Schneider, A 2010, 'AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke.', STROKE, Jg. 41, Nr. 11, 11, S. 2545-2551. <http://www.ncbi.nlm.nih.gov/pubmed/20947859?dopt=Citation>

APA

Schäbitz, W. R., Laage, R., Vogt, G., Koch, W., Kollmar, R., Schwab, S., Schneider, D., Hamann, G. F., Rosenkranz, M., Veltkamp, R., Fiebach, J. B., Hacke, W., Grotta, J. C., Fisher, M., & Schneider, A. (2010). AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. STROKE, 41(11), 2545-2551. [11]. http://www.ncbi.nlm.nih.gov/pubmed/20947859?dopt=Citation

Vancouver

Schäbitz WR, Laage R, Vogt G, Koch W, Kollmar R, Schwab S et al. AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. STROKE. 2010;41(11):2545-2551. 11.

Bibtex

@article{c75721ee01ac4b289f35eb098255f528,
title = "AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke.",
abstract = "Granulocyte colony-stimulating factor (G-CSF) is a promising stroke drug candidate. The present phase IIa study assessed safety and tolerability over a broad dose range of G-CSF doses in acute ischemic stroke patients and explored outcome data.",
author = "Sch{\"a}bitz, {Wolf R} and Rico Laage and Gerhard Vogt and Winfried Koch and Rainer Kollmar and Stefan Schwab and Dietmar Schneider and Hamann, {Gerhard F} and Michael Rosenkranz and Roland Veltkamp and Fiebach, {Jochen B} and Werner Hacke and Grotta, {James C} and Marc Fisher and Armin Schneider",
year = "2010",
language = "Deutsch",
volume = "41",
pages = "2545--2551",
journal = "STROKE",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

RIS

TY - JOUR

T1 - AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke.

AU - Schäbitz, Wolf R

AU - Laage, Rico

AU - Vogt, Gerhard

AU - Koch, Winfried

AU - Kollmar, Rainer

AU - Schwab, Stefan

AU - Schneider, Dietmar

AU - Hamann, Gerhard F

AU - Rosenkranz, Michael

AU - Veltkamp, Roland

AU - Fiebach, Jochen B

AU - Hacke, Werner

AU - Grotta, James C

AU - Fisher, Marc

AU - Schneider, Armin

PY - 2010

Y1 - 2010

N2 - Granulocyte colony-stimulating factor (G-CSF) is a promising stroke drug candidate. The present phase IIa study assessed safety and tolerability over a broad dose range of G-CSF doses in acute ischemic stroke patients and explored outcome data.

AB - Granulocyte colony-stimulating factor (G-CSF) is a promising stroke drug candidate. The present phase IIa study assessed safety and tolerability over a broad dose range of G-CSF doses in acute ischemic stroke patients and explored outcome data.

M3 - SCORING: Zeitschriftenaufsatz

VL - 41

SP - 2545

EP - 2551

JO - STROKE

JF - STROKE

SN - 0039-2499

IS - 11

M1 - 11

ER -